Forward BIOLABS, in partnership with BioForward Wisconsin, announced on Tuesday the first round awardees of the Innovation to Commercialization Pipeline program.
The program supports early-stage biohealth innovation across Wisconsin.
Eighteen early-stage biohealth companies were selected to receive ICP awards, which provide targeted financial support and strategic resources to help startups advance product development, reduce technical and commercial risks and prepare for future investment.
The awardees represent the biomanufacturing, diagnostics, life sciences, medical devices, pharmaceuticals and radiopharmaceuticals industries.
“The ICP program is designed to address a critical early-stage funding gap and strengthen Wisconsin’s homegrown pipeline of investable biohealth companies by supporting founders at pivotal milestones,” Forward BIOLABS said in a statement.
The full list of awardees can be found on the Forward BIOLABS website.
